Subish Palaian

Subish Palaian

Associate Professor
Ext: --

Dr. Subish Palaian is an Associate Professor at College of Pharmacy and Health Sciences, Ajman University. His research experience is mainly related to Pharmacovigilance and Drug Safety.

Education
  • PhD, College of Pharmacy, Universiti Sans Malaysia, Penang, Malaysia, 2010
  • M.Pharm, Manipal Academy of Higher Education, India, 2003
  • B.Pharm, Rajiv Gandhi University of Health Sciences, India, 2000
Experience
  • Associate professor, Department of Pharmacy Practice, Gulf Medical University, Ajman, UAE, 4 years
  • Associate Professor, Department of Pharmacology and Chief of Hospital and Clincial Pharmacy, College of Medical Sciences, Bharatpur, Nepal, 5 years
  • Assistant Professor, Department of Pharmacology, Manipal College of Medical Sciences, Pokhara, Nepal, 3 years
  • Lecturer, Department of Pharmacology, Manipal College of Medical Sciences, Pokhara, Nepal, 3 years
Teaching Area
  • Clinical Pharmacy
  • Infectious diseases
  • Pharmacotherapy
  • Hospital Pharmacy
  • Community Pharmacy
Research
  • Pharmacovigilance
  • Pharmacoepidemiology
  • Rational use of medicines
Publications
  • The use of topical clobetasol among the women in hail region, Saudi Arabia: a cross-sectional study on knowledge and practice. Journal of Pharmaceutical Research International. 2019 Nov 22:1-7
  • Undergraduate pharmacy students’ attitudes and perceived barriers toward provision of pharmaceutical care: a multi-institutional study in Nepal. Integrated Pharmacy Research & Practice 2019; 8:47
  • Impact assessment of pharmacovigilance-related educational intervention on nursing students’ knowledge, attitude and practice: a pre-post study. Journal of Nursing Education and Practice 2019; 9 (6): 98-106
  • Uncommon side effects of commonly used anti-diabetics: Time to monitor them. Int J Pharm Sci & Res 2019; 10(9): 4145-48
  • Pharmacovigilance in perspective: drug withdrawals, data mining and policy implications. F1000Research. 2019 Dec 16;8(2109):2109
  • Overview, Challenges and Future Prospects of Drug Information Services in Nepal: A Reflective Commentary. Journal of Multidisciplinary Healthcare. 2020;13:287
  • The impact of a self-management educational program coordinated through WhatsApp on diabetes control. Pharmacy Practice. 2020 May 3;18(2):1841
  • Bibliometric analysis of adverse drug reactions and pharmacovigilance research activities in Nepal. Therapeutic Advances in Drug Safety 2020 May;11:2042098620922480.
  • Assessment of the Knowledge and Self-medication Practices towards Antibiotics among Future Healthcare Professionals in Ajman, United Arab Emirates. JPRI, 32(9): 24-34, 2020; Article no.JPRI.57354
  • Post marketing surveillance of suspected adverse drug reactions through spontaneous reporting: current status, challenges and the future. Therapeutic Advances in Drug Safety. 2020 Aug;11:2042098620938595.
  • Knowledge, awareness and preparedness regarding coronavirus disease 2019 pandemic among community pharmacy practitioners working in Kathmandu, Nepal: A pilot study. SAGE Open Medicine 2020; 8: 1-11
  • Patient Safety Culture in Handling Prescriptions and Interprofessional Collaboration Practices Amongst Community Pharmacists: An Investigative Simulated Patient Study from the United Arab Emirates. Risk Manag Healthc Policy 2020;13:3201-9
  • Assessment of a pharmacovigilance module: an interventional study on knowledge, attitude and practice of pharmacy students. Journal of Pharmacy and Bioallied Sciences
  • Nationwide survey on attitudes and perceived barriers toward provision of pharmaceutical care among final year undergraduate pharmacy students in the United Arab Emirates. PLoS One. 2021 Feb 16;16(2):e0246934
  • Knowledge and Practice on Ecopharmacovigilance and Medicine Storage Amongst Medical and Dental Students in Lalitpur, Nepal. Risk management and healthcare policy. 2021;14:793
  • Therapeutic dimensions of bisphosphonates: A clinical update. Int J Prev Med 2020;11:166
  • Hydroxychloroquine and chloroquine in prophylaxis and treatment of COVID-19: What is known?. J Pharm Bioall Sci 2021; 13: 4-10
  • Pharmacovigilance of COVID-19 vaccines in the context of Nepal: an assessment based on early adverse drug reaction reports. Journal of Pharmaceutical Health Services Research
  • . Respiratory concerns of gabapentin and pregabalin: What does it mean to the pharmacovigilance systems in developing countries? [version 2; peer review: 2 approved]. F1000Research 2021, 9:32
  • Newer saviour for an older problem: Omecamtiv mecarbil for systolic heart failure. J R Coll Physicians Edinb 2021; 51
Conference Presentation
  • Community pharmacy practice evaluation in the United Arab Emirates using simulated patients with common cold. At the 2020 International Conference of Pharmacoepidemiology and Therapeutic Risk Management September 15-16, 2020; www.ICPE-AllAccess.org
Memberships, Awards and Honors
  • Membership at The International Society for Pharmacoepidemiology